Product information

Arexvy
120 µg + 0.5 ml
respiratoir syncytieel virus
4860383
0 / 10
Locked

Product properties

J07BX05
GlaxoSmithKline Biologicals
Powder and suspension for suspension for injection
EU/1/23/1740/001
08718969852593
M1
Public
661565-02

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Other reason) and no stock is available from wholesalers. Switching to an alternative is necessary.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives

Status history (PharmaStatus)

Commercialization stopped Active
- present

Other reason

Alternative available

Composition

7 ingredients

Substance Type Strength CAS
Active ingredient
120 ug/{dose}
Excipient
Excipient
Excipient
Excipient
Excipient
Excipient
0.18 mg/{dose}

Additional information

View on BCPI

Availability statistics

Commercialization stopped
632 days
3
0
31/12/2025